NCAM1 and Huntington disease: Altogether, these data indicate that, despite combined assessment of CD16 plus NKp80 would be enough for the identification of all NK-cells and their subsets in blood of HD and patients with reactive conditions, CD56 should also be added in cases suspected of NK-cell clonality for a more accurate identification of clonal (aberrant) NK-cells.